While Merck reported strong financial results in recent quarters, it faces both upsides and risks in the future. Read why I'm ...

Drugmaker Merck said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for government ...

Merck‘s performance in 2025 started rough due to weaker-than-expected results, despite surpassing Wall Street estimates with ...

India, Mexico, Brazil, and some other major emerging economies recorded strong growth, while the United States continued to extend its lead as the top destination for direct investment ...

On the sidelines of the inaugural annual global AlUla Conference for Emerging Market Economies in Al Ula, Saudi Arabia (February 16-17), Saudi Arabia's Finance Ministry and the International Monetary ...

UWM Holdings Corporation , the publicly traded indirect parent of United Wholesale Mortgage (UWM), the #1 overall mortgage lender, wholesale and purchase mortgage lender in the U.S., will announce its ...

End-of-Mission press releases include statements of IMF staff teams that convey preliminary findings after a visit to a country. The views expressed in this statement are those of the IMF staff and do ...

MORE than 500 investors have started their claims process against Switzerland for its forced write-down of Credit Suisse’s Additional Tier 1 (AT1) bonds in March 2023, said Singapore law firm Drew & ...

Investors have taken to punishing pharma companies that appear unable to gauge demand for their top products.

Merck (NYSE: MRK) recently released its Q4 results, with revenues and earnings exceeding the street estimates. The company reported revenue of $15.6 billion and adjusted earnings of $1.72 per ...

Merck & Co.’s blockbuster vaccine Gardasil has had a roller-coaster ride in China. A post-Covid surge in demand for the cancer-preventing shot quickly deflated last year, to the point the US ...